The government has announced the achievement of an ambitious goal to accelerate the clinical trial process. Thanks to the reforms implemented, patients will gain faster access to innovative treatment methods that previously could have waited years for approval and implementation in medical practice. The acceleration is linked to the optimization of administrative procedures, reducing coordination time between research institutions, regulators, and pharmaceutical companies. This makes it possible to narrow the gap between drug development and its availability to a broad patient population. Healthcare system representatives note that faster clinical trials are particularly important for patients with severe and rare diseases, where time is a critical factor. Expedited access to experimental treatment methods can significantly improve the chances of successful recovery or improved quality of life. The initiative is viewed as part of a broader healthcare system modernization strategy aimed at increasing its efficiency and international competitiveness. It is expected that such an approach will attract more investment in the biomedical research sector and strengthen the country's position as a center for medical innovation. Authorities emphasized that further steps will focus on consolidating the results achieved and expanding the practice of accelerated trials to new areas of medicine.